tiprankstipranks
Advertisement
Advertisement
Arcus Biosciences price target raised to $29 from $25 at BofA
PremiumThe FlyArcus Biosciences price target raised to $29 from $25 at BofA
4d ago
Buy Rating Reaffirmed on Arcus Biosciences as New RCC Partnerships Strengthen Multi-Line Development Strategy
Premium
Ratings
Buy Rating Reaffirmed on Arcus Biosciences as New RCC Partnerships Strengthen Multi-Line Development Strategy
15d ago
Arcus, Summit enter into clinical trial collaboration over kidney cancer
Premium
The Fly
Arcus, Summit enter into clinical trial collaboration over kidney cancer
15d ago
Arcus Biosciences Stockholders Back Directors and Governance Measures
PremiumCompany AnnouncementsArcus Biosciences Stockholders Back Directors and Governance Measures
2M ago
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
Premium
Company Announcements
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
2M ago
Arcus Biosciences initiated with an Outperform at LifeSci Capital
Premium
The Fly
Arcus Biosciences initiated with an Outperform at LifeSci Capital
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100